The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy

Antiviral Research

Volumn 15, Issue 4, 1991, Pages 287-300

  Coen, Donald M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antiviral drug; Drug resistance; Herpesvirus; Nucleoside analog

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FOSCARNET; GANCICLOVIR; IDOXURIDINE; NUCLEOSIDE ANALOG; VIDARABINE;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG RESISTANCE; HERPES; HERPES VIRUS; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ANIMAL; ANTIVIRAL AGENTS; DRUG RESISTANCE, MICROBIAL; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMAN; SUPPORT, U.S. GOV'T, P.H.S.;

ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 5; SIMPLEXVIRUS;

EID: 0025803671     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(91)90010-O     Document Type: Short Survey

References (56)

1. Studies on the biochemical basis for the antiviral activities of some nucleoside analogs
2. A human cytomegalovirus mutant resistant to the nucleoside analog 9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}guanine (BW B759U) induces reduced levels of BW B759U triphosphate
3. Metabolic activation of the nucleoside analog 9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}guanine in human diploid fibroblasts infected with human cytomegalovirus
4. Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target
5. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome
6. General aspects of virus drug resistance with special reference to herpes simplex virus
7. Genetics of acycloguanosine resistance and the thymidine kinase gene in HSV-1
8. Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-β-d-arabinofuranosyladenine
9. Low levels of herpes simplex virus thymidine-thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model
10. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate
11. Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1
12. Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir
13. Cooperative effects between two acyclovir resistance loci in herpes simplex virus
14. Characterization of the DNA polymerases induced by a group of herpes simplex type 1 variants selected for growth in the presence of phosphonoformic acid
15. A novel functional domain of an α-like DNA polymerase: the binding site on the herpes simplex virus polymerase for the viral UL42 protein
16. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis
17. Herpes simplex virus resistant to acyclovir: a study in a tertiary care center
18. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity
19. Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1
20. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients
21. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS): an uncontrolled trial
22. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome
23. Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy
24. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir
25. Activity of 9-(1,3,-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses
26. Inhibition of herpes simplex virus induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate
27. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound 9-(2-hydroxyethoxymethyl)guanine
28. Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition
29. Generation of genetic diversity in herpes simplex virus: an antimutator phenotype maps to the DNA polymerase locus
30. Reduced in vivo mutagenesis by mutant herpes simplex DNA polymerase involves improved nucleotide selection
31. Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site
32. A working hypothesis - virus resistance development as an indicator of specific antiviral activity
33. Resistance to antiviral drugs: the end of innocence
34. Effect of an amber mutation in the herpes simplex virus thymidine kinase gene on polypeptide synthesis and stability
35. A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells
36. Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants
37. Nucleotide sequence of the DNA polymerase gene of herpes simplex virus type 1 strain Angelotti
38. Virus drug resistance: mechanisms and consequences
39. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy
40. Related functional domains in virus DNA polymerases
41. Specific inhibitors of herpes simplex virus thymidine kinase diminish reactivation of latent virus from explanted murine ganglia
42. Mechanism of phosphonoacetate inhibition of herpesvirus-induced DNA polymerase
43. Latent infections in spinal ganglia with thymidine kinase-deficient herpes simplex virus
44. Engineered herpes simplex virus DNA polymerase point mutants: the most highly conserved region shared among α-like DNA polymerases is involved in substrate recognition
45. Phosphorylation of acyclovir monophosphate by GMP kinase
46. Phosphorylation of acyclovir diphosphate by cellular enzymes
47. Severe progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS
48. Biological and biochemical characterization of clinical isolates of herpes simplex virus type 2 resistant to acyclovir
49. Acyclovir-resistant herpes simplex virus infection due to altered DNA polymerase
50. Progressive esophagitis from acyclovir-resistant herpes simplex: clinical roles for DNA polymerase mutants and viral heterogeneity?
51. Inhibition of cellular α DNA polymerase and herpes simplex virus-induced DNA polymerases by the triphosphate of BW759U
52. Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglia
53. Latency-associated transcript but not reactivatable virus is present in sensory ganglion neurons after inoculation of thymidine kinase-negative mutants of herpes simplex virus type 1
54. A single base change within the DNA polymerase locus of herpes simplex virus type 2 can confer resistance to aphidicolin
55. Chronic herpetic infection in an immunocompromised patient: report of a case
56. Acyclovir-resistant herpes in AIDS treated with foscarnet